Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.

Herrero-Cervera A, Vinué Á, Burks DJ, González-Navarro H.

Diabetologia. 2019 Nov;62(11):2143-2157. doi: 10.1007/s00125-019-4962-6. Epub 2019 Aug 6.

PMID:
31388695
2.

Type 1 diabetic mellitus patients with increased atherosclerosis risk display decreased CDKN2A/2B/2BAS gene expression in leukocytes.

Martínez-Hervás S, Sánchez-García V, Herrero-Cervera A, Vinué Á, Real JT, Ascaso JF, Burks DJ, González-Navarro H.

J Transl Med. 2019 Jul 12;17(1):222. doi: 10.1186/s12967-019-1977-1.

3.

Changes in CDKN2A/2B expression associate with T-cell phenotype modulation in atherosclerosis and type 2 diabetes mellitus.

VinuÉ Á, MartÍnez-HervÁs S, Herrero-Cervera A, SÁnchez-GarcÍa V, AndrÉs-Blasco I, Piqueras L, Sanz MJ, Real JT, Ascaso JF, Burks DJ, GonzÁlez-Navarro H.

Transl Res. 2019 Jan;203:31-48. doi: 10.1016/j.trsl.2018.08.003. Epub 2018 Aug 15.

PMID:
30176239
4.

Understanding the Impact of Dietary Cholesterol on Chronic Metabolic Diseases through Studies in Rodent Models.

Vinué Á, Herrero-Cervera A, González-Navarro H.

Nutrients. 2018 Jul 21;10(7). pii: E939. doi: 10.3390/nu10070939. Review.

5.

The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype.

Vinué Á, Navarro J, Herrero-Cervera A, García-Cubas M, Andrés-Blasco I, Martínez-Hervás S, Real JT, Ascaso JF, González-Navarro H.

Diabetologia. 2017 Sep;60(9):1801-1812. doi: 10.1007/s00125-017-4330-3. Epub 2017 Jun 12.

PMID:
28608285
6.

Hepatic lipase inactivation decreases atherosclerosis in insulin resistance by reducing LIGHT/Lymphotoxin β-Receptor pathway.

Andrés-Blasco I, Vinué Á, Herrero-Cervera A, Martínez-Hervás S, Nuñez L, Piqueras L, Ascaso JF, Sanz MJ, Burks DJ, González-Navarro H.

Thromb Haemost. 2016 Aug 1;116(2):379-93. doi: 10.1160/TH15-10-0773. Epub 2016 May 12.

PMID:
27172975
7.

Glucose and Insulin Tolerance Tests in the Mouse.

Vinué Á, González-Navarro H.

Methods Mol Biol. 2015;1339:247-54. doi: 10.1007/978-1-4939-2929-0_17.

PMID:
26445794
8.

Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis.

Andrés-Blasco I, Herrero-Cervera A, Vinué Á, Martínez-Hervás S, Piqueras L, Sanz MJ, Burks DJ, González-Navarro H.

J Endocrinol. 2015 Dec;227(3):179-91. doi: 10.1530/JOE-15-0219. Epub 2015 Sep 30.

PMID:
26423094
9.

Ink4/Arf locus restores glucose tolerance and insulin sensitivity by reducing hepatic steatosis and inflammation in mice with impaired IRS2-dependent signalling.

Vinué Á, Andrés-Blasco I, Herrero-Cervera A, Piqueras L, Andrés V, Burks DJ, Sanz MJ, González-Navarro H.

Biochim Biophys Acta. 2015 Sep;1852(9):1729-42. doi: 10.1016/j.bbadis.2015.05.013. Epub 2015 May 31.

10.

Impact of estrogens on atherosclerosis and bone in the apolipoprotein E-deficient mouse model.

Fernández-Murga ML, Vinué Á, Caeiro JR, Guede D, Tarín JJ, Andrés V, Cano A.

Menopause. 2015 Apr;22(4):428-36. doi: 10.1097/GME.0000000000000328.

PMID:
25203894
11.

Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis.

Martínez-Hervás S, Vinué A, Núñez L, Andrés-Blasco I, Piqueras L, Real JT, Ascaso JF, Burks DJ, Sanz MJ, González-Navarro H.

Cardiovasc Res. 2014 Jul 15;103(2):324-36. doi: 10.1093/cvr/cvu115. Epub 2014 Apr 29.

PMID:
24788416
12.

Increased dosage of Ink4/Arf protects against glucose intolerance and insulin resistance associated with aging.

González-Navarro H, Vinué Á, Sanz MJ, Delgado M, Pozo MA, Serrano M, Burks DJ, Andrés V.

Aging Cell. 2013 Feb;12(1):102-11. doi: 10.1111/acel.12023. Epub 2012 Dec 5.

13.

Increased gene dosage of the Ink4/Arf locus does not attenuate atherosclerosis development in hypercholesterolaemic mice.

Fuster JJ, Molina-Sánchez P, Jovaní D, Vinué Á, Serrano M, Andrés V.

Atherosclerosis. 2012 Mar;221(1):98-105. doi: 10.1016/j.atherosclerosis.2011.12.013. Epub 2011 Dec 17.

PMID:
22226369
14.

Deficient p27 phosphorylation at serine 10 increases macrophage foam cell formation and aggravates atherosclerosis through a proliferation-independent mechanism.

Fuster JJ, González-Navarro H, Vinué A, Molina-Sànchez P, Andrés-Manzano MJ, Nakayama KI, Nakayama K, Díez-Juan A, Bernad A, Rodríguez C, Martínez-González J, Andrés V.

Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2455-63. doi: 10.1161/ATVBAHA.111.235580.

PMID:
21885849
15.

p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis.

González-Navarro H, Abu Nabah YN, Vinué A, Andrés-Manzano MJ, Collado M, Serrano M, Andrés V.

J Am Coll Cardiol. 2010 May 18;55(20):2258-68. doi: 10.1016/j.jacc.2010.01.026. Epub 2010 Apr 8.

16.

Molecular mechanisms of atherosclerosis in metabolic syndrome: role of reduced IRS2-dependent signaling.

González-Navarro H, Vinué A, Vila-Caballer M, Fortuño A, Beloqui O, Zalba G, Burks D, Díez J, Andrés V.

Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2187-94. doi: 10.1161/ATVBAHA.108.175299. Epub 2008 Sep 18.

17.

Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth muscle cell proliferation.

Verdeguer F, Castro C, Kubicek M, Pla D, Vila-Caballer M, Vinué A, Civeira F, Pocoví M, Calvete JJ, Andrés V.

Cardiovasc Res. 2007 Nov 1;76(2):340-50. Epub 2007 Jul 4.

18.

Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice.

Gonzalez-Navarro H, Vila-Caballer M, Pastor MF, Vinue A, White MF, Burks D, Andres V.

Front Biosci. 2007 Jan 1;12:2291-8.

Supplemental Content

Loading ...
Support Center